Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 2Suspended 1Recruiting 1

Sponsor Class

OTHER 43INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 3210Carcinoma, Non-Small-Cell Lung 2721Breast Neoplasms 2547Colorectal Neoplasms 1454Prostatic Neoplasms 1303Neoplasm Metastasis 1292Multiple Myeloma 1109Melanoma 1101Ovarian Neoplasms 1001Lung Neoplasms 941Recurrence 921Leukemia, Myeloid, Acute 876Pancreatic Neoplasms 830Lymphoma, Non-Hodgkin 766Lymphoma 713Stomach Neoplasms 691Carcinoma, Renal Cell 658Carcinoma, Hepatocellular 645Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 546Lymphoma, Follicular 515Head and Neck Neoplasms 488Glioblastoma 472Small Cell Lung Carcinoma 444Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 433Advanced Solid Tumors 430Leukemia 426Uterine Cervical Neoplasms 418Urinary Bladder Neoplasms 405

Interventions

Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Medication Adherence × Clear all
NCT05459454 2025-05-25

A Digital Solution for Breast Cancer Patients

Sidekick Health

Phase NA Completed
64 enrolled
Breast

Breast Neoplasms, Motor Activity, Medication Adherence

NCT05801965 2025-05-25

A Digital Therapeutic Solution for Cancer Patients

Sidekick Health

Phase NA Completed
48 enrolled
GastrointestinalGenitourinaryThoracic

Lung Neoplasms, Motor Activity, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Medication Adherence

NCT06989450 2025-05-25

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Sidekick Health

Phase NA Recruiting
140 enrolled
Breast

Breast Neoplasms, Neoplasms, Medication Adherence

NCT04091711 2021-09-20

Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics

Dosentrx Ltd.

Phase NA Suspended
20 enrolled

Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡